The North American geriatric medicine market is projected to grow at a CAGR of 4.9% during the forecast period. The healthcare expenditure rate of North America is high on R&D and there is more business opportunity in the US as compared to Canada. The major factors that are driving the North American market include rising healthcare spending, R&D investments, and quality of healthcare infrastructure. The changing lifestyle is also a major factor that increases the possibilities of diseases such as cancer in North America such as inadequate diet, consumption of alcohol, and smoking. These factors drive the geriatric medicine industry in North America.
A full report of North America Geriatric Medicine Market is available at: https://www.omrglobal.com/industry-reports/north-american-geriatric-medicine-market
The US spends more on healthcare than any other developed economy. The reason for more healthcare expenditure is the large GDP growth of the nation. NHEA measures annual US expenditures for health care goods and services, public health activities, government administration, the net cost of health insurance, and investment regarding healthcare. There are several research segments in the US that tend to invest in the research of healthcare and medical drugs, medical devices, and others. The sectors that invest in healthcare and medical researchers include the federal government, academic and research institutes, non-research conducting grant-giving entities, state, and local government.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-geriatric-medicine-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Therapeutics and By Condition
- Countries Covered- US and Canada
- Key Companies Profiled- Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories, Johnson & Johnson Services Inc., Eli Lilly and Co., Boehringer Ingelheim GmbH, and AstraZeneca PLC
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
North America Geriatric Medicine Market – Segmentation
By Therapeutics
- Analgesic
- Anticoagulant
- Antihypertensive
- Antidiabetic
- Others (Statins and Antipsychotic)
By Condition
- Cardiovascular Diseases (CVDs)
- Diabetes
- Neurological
- Cancer
- Respiratory
- Others (Arthritis and Osteoporosis)
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
